HEADER TRANSFERASE 20-SEP-07 2RCW TITLE PARP COMPLEXED WITH A620223 COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PARP ALPHA-HELICAL AND PARP CATALYTIC DOMAINS; COMPND 5 SYNONYM: PARP-1, ADPRT, NAD+, ADP-RIBOSYLTRANSFERASE 1, POLY[ADP- COMPND 6 RIBOSE] SYNTHETASE 1; COMPND 7 EC: 2.4.2.30; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 GENE: PARP1, ADPRT, PPOL; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI KEYWDS PROTEIN-INHIBITOR COMPLEX, ADP-RIBOSYLATION, DNA DAMAGE, DNA REPAIR, KEYWDS 2 DNA-BINDING, GLYCOSYLTRANSFERASE, METAL-BINDING, NAD, NUCLEUS, KEYWDS 3 PHOSPHORYLATION, POLYMORPHISM, TRANSFERASE, ZINC, ZINC-FINGER EXPDTA X-RAY DIFFRACTION AUTHOR C.H.PARK REVDAT 3 30-AUG-23 2RCW 1 REMARK REVDAT 2 24-FEB-09 2RCW 1 VERSN REVDAT 1 23-SEP-08 2RCW 0 JRNL AUTH C.H.PARK JRNL TITL PARP COMPLEXED WITH A620223 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 844637.270 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 87.2 REMARK 3 NUMBER OF REFLECTIONS : 7722 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.245 REMARK 3 R VALUE (WORKING SET) : 0.234 REMARK 3 FREE R VALUE : 0.317 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.700 REMARK 3 FREE R VALUE TEST SET COUNT : 826 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.011 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 8989 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.79 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.89 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 56.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 441 REMARK 3 BIN R VALUE (WORKING SET) : 0.3540 REMARK 3 BIN FREE R VALUE : 0.4390 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 53 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.060 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2752 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 21 REMARK 3 SOLVENT ATOMS : 132 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 44.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -10.30000 REMARK 3 B22 (A**2) : -10.30000 REMARK 3 B33 (A**2) : 20.61000 REMARK 3 B12 (A**2) : 3.11000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM SIGMAA (A) : 0.41 REMARK 3 LOW RESOLUTION CUTOFF (A) : 6.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.53 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.60 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.002 REMARK 3 BOND ANGLES (DEGREES) : 0.800 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.550 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.780 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.000 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.590 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.000 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.26 REMARK 3 BSOL : 27.26 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.P REMARK 3 PARAMETER FILE 2 : ACCELRYS_CNX_TOPPAR:WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ACCELRYS_CNX_TOPPAR:ION.PARAM REMARK 3 PARAMETER FILE 4 : LIG.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : LIG.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2RCW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-OCT-07. REMARK 100 THE DEPOSITION ID IS D_1000044707. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JUL-04 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 32-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NOT SURE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8157 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.7 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08100 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.79 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.89 REMARK 200 COMPLETENESS FOR SHELL (%) : 65.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.31200 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1UK0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN 60MG/ML IN 50 MM TRIS, 150 MM REMARK 280 NACL, 1.5 MM DTT PH 7.5; WELL SOLUTION CONTAINS 1.3 M AMMONIUM REMARK 280 SULFATE, 1.3 M NACL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 3 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z REMARK 290 6555 -X,-X+Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 101 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 31 104.34 -52.69 REMARK 500 SER A 64 77.49 57.97 REMARK 500 ASP A 65 -164.31 49.08 REMARK 500 SER A 66 -86.27 52.64 REMARK 500 LYS A 86 -91.72 160.68 REMARK 500 LYS A 87 101.25 178.09 REMARK 500 PRO A 88 112.16 -36.33 REMARK 500 PRO A 89 107.27 -36.14 REMARK 500 ARG A 118 64.85 -113.25 REMARK 500 SER A 121 79.87 -118.61 REMARK 500 ASP A 123 -161.97 -74.55 REMARK 500 THR A 160 8.48 -65.83 REMARK 500 ALA A 162 -162.23 -62.66 REMARK 500 HIS A 165 39.02 -84.93 REMARK 500 ASN A 166 42.31 -92.31 REMARK 500 VAL A 172 95.21 -65.05 REMARK 500 LYS A 177 74.82 -104.59 REMARK 500 GLU A 179 91.83 178.60 REMARK 500 HIS A 194 166.88 -49.06 REMARK 500 ASN A 195 70.71 63.83 REMARK 500 THR A 206 11.09 -68.28 REMARK 500 ASN A 245 5.25 -65.41 REMARK 500 TYR A 269 75.47 -109.59 REMARK 500 SER A 275 88.73 -162.58 REMARK 500 ILE A 277 -99.63 -141.62 REMARK 500 SER A 278 30.02 91.61 REMARK 500 LYS A 279 53.46 -152.83 REMARK 500 LEU A 280 141.89 -39.65 REMARK 500 LYS A 282 98.03 -60.24 REMARK 500 ASP A 296 104.45 -50.17 REMARK 500 LEU A 310 35.83 -86.69 REMARK 500 ASP A 320 45.91 -84.10 REMARK 500 GLU A 327 106.70 -164.91 REMARK 500 LYS A 343 72.57 -103.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AAI A 400 DBREF 2RCW A 1 350 UNP P09874 PARP1_HUMAN 662 1011 SEQRES 1 A 350 LYS SER LYS LEU PRO LYS PRO VAL GLN ASP LEU ILE LYS SEQRES 2 A 350 MET ILE PHE ASP VAL GLU SER MET LYS LYS ALA MET VAL SEQRES 3 A 350 GLU TYR GLU ILE ASP LEU GLN LYS MET PRO LEU GLY LYS SEQRES 4 A 350 LEU SER LYS ARG GLN ILE GLN ALA ALA TYR SER ILE LEU SEQRES 5 A 350 SER GLU VAL GLN GLN ALA VAL SER GLN GLY SER SER ASP SEQRES 6 A 350 SER GLN ILE LEU ASP LEU SER ASN ARG PHE TYR THR LEU SEQRES 7 A 350 ILE PRO HIS ASP PHE GLY MET LYS LYS PRO PRO LEU LEU SEQRES 8 A 350 ASN ASN ALA ASP SER VAL GLN ALA LYS VAL GLU MET LEU SEQRES 9 A 350 ASP ASN LEU LEU ASP ILE GLU VAL ALA TYR SER LEU LEU SEQRES 10 A 350 ARG GLY GLY SER ASP ASP SER SER LYS ASP PRO ILE ASP SEQRES 11 A 350 VAL ASN TYR GLU LYS LEU LYS THR ASP ILE LYS VAL VAL SEQRES 12 A 350 ASP ARG ASP SER GLU GLU ALA GLU ILE ILE ARG LYS TYR SEQRES 13 A 350 VAL LYS ASN THR HIS ALA THR THR HIS ASN ALA TYR ASP SEQRES 14 A 350 LEU GLU VAL ILE ASP ILE PHE LYS ILE GLU ARG GLU GLY SEQRES 15 A 350 GLU CYS GLN ARG TYR LYS PRO PHE LYS GLN LEU HIS ASN SEQRES 16 A 350 ARG ARG LEU LEU TRP HIS GLY SER ARG THR THR ASN PHE SEQRES 17 A 350 ALA GLY ILE LEU SER GLN GLY LEU ARG ILE ALA PRO PRO SEQRES 18 A 350 GLU ALA PRO VAL THR GLY TYR MET PHE GLY LYS GLY ILE SEQRES 19 A 350 TYR PHE ALA ASP MET VAL SER LYS SER ALA ASN TYR CYS SEQRES 20 A 350 HIS THR SER GLN GLY ASP PRO ILE GLY LEU ILE LEU LEU SEQRES 21 A 350 GLY GLU VAL ALA LEU GLY ASN MET TYR GLU LEU LYS HIS SEQRES 22 A 350 ALA SER HIS ILE SER LYS LEU PRO LYS GLY LYS HIS SER SEQRES 23 A 350 VAL LYS GLY LEU GLY LYS THR THR PRO ASP PRO SER ALA SEQRES 24 A 350 ASN ILE SER LEU ASP GLY VAL ASP VAL PRO LEU GLY THR SEQRES 25 A 350 GLY ILE SER SER GLY VAL ASN ASP THR SER LEU LEU TYR SEQRES 26 A 350 ASN GLU TYR ILE VAL TYR ASP ILE ALA GLN VAL ASN LEU SEQRES 27 A 350 LYS TYR LEU LEU LYS LEU LYS PHE ASN PHE LYS THR HET AAI A 400 21 HETNAM AAI TRANS-4-(7-CARBAMOYL-1H-BENZIMIDAZOL-2-YL)-1- HETNAM 2 AAI PROPYLPIPERIDINIUM HETSYN AAI 2-(1-PROPYL-PIPERIDIN-4-YL)-1H-BENZOIMIDAZOLE-4- HETSYN 2 AAI CARBOXYLIC ACID AMIDE FORMUL 2 AAI C16 H22 N4 O FORMUL 3 HOH *132(H2 O) HELIX 1 1 PRO A 5 ILE A 15 1 11 HELIX 2 2 ASP A 17 GLU A 27 1 11 HELIX 3 3 PRO A 36 LEU A 40 5 5 HELIX 4 4 SER A 41 SER A 60 1 20 HELIX 5 5 SER A 66 THR A 77 1 12 HELIX 6 6 ASN A 93 ARG A 118 1 26 HELIX 7 7 ASP A 127 LYS A 137 1 11 HELIX 8 8 SER A 147 THR A 160 1 14 HELIX 9 9 TYR A 187 GLN A 192 1 6 HELIX 10 10 ARG A 204 THR A 206 5 3 HELIX 11 11 ASN A 207 GLY A 215 1 9 HELIX 12 12 MET A 239 ALA A 244 1 6 HELIX 13 13 ASN A 245 CYS A 247 5 3 HELIX 14 14 PRO A 297 ASN A 300 5 4 HELIX 15 15 ASP A 332 ALA A 334 5 3 SHEET 1 A 2 TYR A 168 ASP A 169 0 SHEET 2 A 2 ASN A 347 PHE A 348 -1 O ASN A 347 N ASP A 169 SHEET 1 B 4 VAL A 172 PHE A 176 0 SHEET 2 B 4 VAL A 336 LYS A 345 -1 O LYS A 343 N ASP A 174 SHEET 3 B 4 ILE A 255 ALA A 264 -1 N GLU A 262 O ASN A 337 SHEET 4 B 4 ARG A 196 GLY A 202 -1 N HIS A 201 O LEU A 259 SHEET 1 C 4 ILE A 234 TYR A 235 0 SHEET 2 C 4 TYR A 328 VAL A 330 -1 O VAL A 330 N ILE A 234 SHEET 3 C 4 SER A 286 GLY A 289 -1 N VAL A 287 O ILE A 329 SHEET 4 C 4 MET A 268 LEU A 271 1 N LEU A 271 O LYS A 288 SHEET 1 D 2 THR A 293 PRO A 295 0 SHEET 2 D 2 GLY A 313 SER A 315 -1 O ILE A 314 N THR A 294 SHEET 1 E 2 ILE A 301 LEU A 303 0 SHEET 2 E 2 VAL A 306 VAL A 308 -1 O VAL A 308 N ILE A 301 SITE 1 AC1 11 VAL A 101 ASP A 105 HIS A 201 GLY A 202 SITE 2 AC1 11 TYR A 228 TYR A 235 PHE A 236 LYS A 242 SITE 3 AC1 11 SER A 243 TYR A 246 GLU A 327 CRYST1 94.166 94.166 68.380 90.00 90.00 120.00 P 3 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010620 0.006131 0.000000 0.00000 SCALE2 0.000000 0.012262 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014624 0.00000